Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients by Léopold, Valentine, Gayat, Etienne, Pirracchio, Romain, Spinar, Jindrich, Parenica, Jiri, Tarvasmäki, Tuukka, Lassus, Johan, Harjola, Veli-Pekka, Champion, Sébastien, Zannad, Faiez, Valente, Serafina, Urban, Philip, Chua, Horng-Ruey, Bellomo, Rinaldo, Popovic, Batric, Ouweneel, Dagmar M., Henriques, José P. S., Simonis, Gregor, Lévy, Bruno, Kimmoun, Antoine, Gaudard, Philippe, Basir, Mir Babar, Markota, Andrej, Adler, Christoph, Reuter, Hannes, Mebazaa, Alexandre, Chouihed, Tahar

Get full text

Response to comment on the editorial by Turner et al. on assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by... by Zannad, Faiez

Get full text

Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis by Jhund, Pardeep S, Talebi, Atefeh, Henderson, Alasdair D, Claggett, Brian L, Vaduganathan, Muthiah, Desai, Akshay S, Lam, Carolyn S P, Pitt, Bertram, Senni, Michele, Shah, Sanjiv J, Voors, Adriaan A, Zannad, Faiez, Solomon, Scott D, McMurray, John J V

Get full text

Hyperkalemia in Heart Failure by Sarwar, Chaudhry M.S., MD, Papadimitriou, Lampros, MD, PhD, Pitt, Bertram, MD, Piña, Ileana, MD, MPH, Zannad, Faiez, MD, Anker, Stefan D., MD, PhD, Gheorghiade, Mihai, MD, Butler, Javed, MD, MPH, MBA

Get full text

Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient... by Rossello, Xavier, Ariti, Cono, Pocock, Stuart J., Ferreira, João Pedro, Girerd, Nicolas, McMurray, John J. V., Van Veldhuisen, Dirk J., Pitt, Bertram, Zannad, Faiez

Get full text

Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial by Packer, Milton, Zannad, Faiez, Butler, Javed, Filippatos, Gerasimos, Ferreira, Joao Pedro, Pocock, Stuart J., Brueckmann, Martina, Zeller, Cordula, Hauske, Sibylle, Anker, Stefan D.

Get full text

Heart Failure and Kidney Disease in Type 2 Diabetes by Zannad, Faiez

Get full text

Heart Failure and Kidney Disease in Type 2 Diabetes: 2 Sides of the Same Coin by Zannad, Faiez

Get full text

Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectives by Pitt, Bertram, Pedro Ferreira, João, Zannad, Faiez

Get full text

Mineralocorticoid receptor antagonists in patients with acute myocardial infarction — A systematic review and meta-analysis of randomized trials by Bossard, Matthias, Binbraik, Yasser, Beygui, Farzin, Pitt, Bertram, Zannad, Faiez, Montalescot, Gilles, Jolly, Sanjit S.

Get full text

Waist‐to‐hip ratio and mortality in heart failure by Streng, Koen W., Voors, Adriaan A., Hillege, Hans L., Anker, Stefan D., Cleland, John G., Dickstein, Kenneth, Filippatos, Gerasimos, Metra, Marco, Ng, Leong L., Ponikowski, Piotr, Samani, Nilesh J., van Veldhuisen, Dirk J., Zwinderman, Aeilko H., Zannad, Faiez, Damman, Kevin, van der Meer, Peter, Lang, Chim C.

Get full text

Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus by Elharram, Malik, Sharma, Abhinav, White, William, Bakris, George, Rossignol, Patrick, Mehta, Cyrus, Ferreira, João Pedro, Zannad, Faiez

Get full text

Long-term vagal stimulation for heart failure: Eighteen month results from the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial by De Ferrari, Gaetano M, Stolen, Craig, Tuinenburg, Anton E, Jay Wright, D, Brugada, Josep, Butter, Christian, Klein, Helmut, Neuzil, Petr, Botman, Cornelis, Castel, Maria Angeles, D'Onofrio, Antonio, De Borst, Gert Jan, Solomon, Scott, Stein, Kenneth M, Schubert, Bernd, Stalsberg, Kevin, Wold, Nicholas, Ruble, Stephen, Zannad, Faiez

Get full text

Angiotensin–neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure by Mc Causland, Finnian R., Lefkowitz, Martin P., Claggett, Brian, Packer, Milton, Senni, Michele, Gori, Mauro, Jhund, Pardeep S., McGrath, Martina M., Rouleau, Jean L., Shi, Victor, Swedberg, Karl, Vaduganathan, Muthiah, Zannad, Faiez, Pfeffer, Marc A., Zile, Michael, McMurray, John J.V., Solomon, Scott D.

Get full text

First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF by Zile, Michael R., Abraham, William T., Lindenfeld, JoAnn, Weaver, Fred A., Zannad, Faiez, Graves, Todd, Rogers, Tyson, Galle, Elizabeth G.

Get full text

MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials by Zannad, Faiez, Sanyal, Arun J., Butler, Javed, Ferreira, João Pedro, Girerd, Nicolas, Miller, Veronica, Pandey, Ambarish, Parikh, Chirag R., Ratziu, Vlad, Younossi, Zobair M., Harrison, Stephen A.

Get full text

Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models by Bonnard, Benjamin, Martínez-Martínez, Ernesto, Fernández-Celis, Amaya, Pieronne-Deperrois, Marie, Do, Quoc-Tuan, Ramos, Isbaal, Rossignol, Patrick, Zannad, Faiez, Mulder, Paul, Ouvrard-Pascaud, Antoine, López-Andrés, Natalia, Jaisser, Frédéric

Get full text

External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial by Razaghizad, Amir, Sharma, Abhinav, Ni, Jiayi, Ferreira, João Pedro, White, William B., Mehta, Cyrus R., Bakris, George L., Zannad, Faiez

Get full text

Management of heart failure around the globe. Are we doing enough? by Zannad, Faiez

Get full text

Serum potassium in the PARADIGM‐HF trial by Ferreira, João Pedro, Mogensen, Ulrik M., Jhund, Pardeep S., Desai, Akshay S., Rouleau, Jean‐Lucien, Zile, Michael R., Rossignol, Patrick, Zannad, Faiez, Packer, Milton, Solomon, Scott D., McMurray, John J.V.

Get full text